|
At the start of treatment
|
1 month of treatment
|
At the end of treatment
|
P-value
|
---|
Fibroscan
|
F0–F1
|
113
|
56.5%
|
113
|
56.5%
|
111
|
55.5%
|
P1 = 1.0 NS
P2 = 0.973 NS
P3 = 0.973 NS
|
F1–F2
|
55
|
27.5%
|
55
|
27.5%
|
57
|
28.5%
|
F3–F4
|
32
|
16.5%
|
32
|
16.5%
|
32
|
16.5%
|
- X2: chi-square test
- S: p-value < 0.05 is considered significant
- HS: p-value < 0.001 is considered highly significant
- P1: refers to the statistical difference between the start of DAA and 1 month after DAA
- P2: refers to the statistical difference between the start of DAA and the end of DAA
- P3: refers to the statistical difference between 1 month after DAA and the end of DAA